Title : Is there a place for crizotinib in c-MET alterations? A case of efficacy in ALK positive NSCLC patient with secondary c-MET amplification.

Pub. Date : 2020 Mar

PMID : 32067689






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Is there a place for crizotinib in c-MET alterations? crizotinib MET proto-oncogene, receptor tyrosine kinase Homo sapiens